Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system

被引：262
|
作者：
Huang, Gangliang [1 ]
Huang, Hualiang [2 ]
机构：
[1] Chongqing Normal Univ, Act Carbohydrate Res Inst, Chongqing 401331, Peoples R China
[2] Wuhan Inst Technol, Sch Chem & Environm Engn, Wuhan 430073, Hubei, Peoples R China
来源：
JOURNAL OF CONTROLLED RELEASE | 2018年 / 278卷
关键词：
Hyaluronic acid; Carrier; Sustained release; Biopharmaceutical delivery; Tumor-targeted drug delivery; RELEASE FORMULATION; PACLITAXEL DELIVERY; SUSTAINED-RELEASE; NANOPARTICLES; SIRNA; CONJUGATE; LIPOSOMES; LUNG; DERIVATIVES; RESISTANCE;
D O I：
10.1016/j.jconrel.2018.04.015
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hyaluronic acid (HA) is a natural polysaccharide with good biocompatibility and degradability. HA and its derivatives can be used as sustained-release carriers for drugs, which can delay the release of drugs and have a long-acting effect. They can be used for the delivery of various drugs such as proteins, nucleic acids and antitumor drugs. HA and its derivatives can specifically bind to multiple receptors on the cell surface and can be used for targeted drug delivery, especially for the delivery of anti-tumor drugs. Thus, there are different forms of tumor-targeted drug delivery systems based on HA.
引用
收藏
页码：122 / 126
页数：5
相关论文
共 50 条
  • [21] Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery
    Yoon, Hong Yeol
    Koo, Heebeom
    Choi, Ki Young
    Kwon, Ick Chan
    Choi, Kuiwon
    Park, Jae Hyung
    Kim, Kwangmeyung
    BIOMATERIALS, 2013, 34 (21) : 5273 - 5280
  • [22] Layer-by-layer nanocomposite based on zein and hyaluronic acid for tumor-targeted gene delivery
    Liu, Liang
    Wang, Tiange
    Sun, Yanlin
    Qi, Guowei
    Guan, Jintao
    Lv, Peiwen
    Chen, Xin
    Zeng, Dong
    INDUSTRIAL CROPS AND PRODUCTS, 2024, 222
  • [23] Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery
    Lee, Jae-Young
    Chung, Suk-Jae
    Cho, Hyun-Jong
    Kim, Dae-Duk
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 94 : 532 - 541
  • [24] Drug Nanocrystals for Active Tumor-Targeted Drug Delivery
    Lu, Linwei
    Xu, Qianzhu
    Wang, Jun
    Wu, Sunyi
    Luo, Zimiao
    Lu, Weiyue
    PHARMACEUTICS, 2022, 14 (04)
  • [25] A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery
    Shen, Yan
    Wang, Buhai
    Lu, Yang
    Ouahab, Ammar
    Li, Qian
    Tu, Jiasheng
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 414 (1-2) : 233 - 243
  • [26] Chitosan-based nanoparticles for tumor-targeted drug delivery
    Prabaharan, M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2015, 72 : 1313 - 1322
  • [27] Strategies for Hyaluronic Acid-Based Hydrogel Design in Drug Delivery
    Trombino, Sonia
    Servidio, Camilla
    Curcio, Federica
    Cassano, Roberta
    PHARMACEUTICS, 2019, 11 (08)
  • [28] Hyaluronic acid-based hydrogels: As an exosome delivery system in bone regeneration
    Deng, Huiling
    Wang, Jiecong
    An, Ran
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] Recent studies on modulating hyaluronic acid-based hydrogels for controlled drug delivery
    Kim, Min-Hwan
    Duy-Thuc Nguyen
    Kim, Dae-Duk
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2022, 52 (04) : 397 - 413
  • [30] Hypoxia-responsive nanoparticles for tumor-targeted drug delivery
    Li, Yuce
    Jeon, Jueun
    Park, Jae Hyung
    CANCER LETTERS, 2020, 490 : 31 - 43
12345